SRD5A1 (3-oxo-5-alpha-steroid 4-dehydrogenase 2) Polyclonal Antibody, APC-Cy7 Conjugated
Katalog-Nummer bs-11308R-APC-Cy7
Size : 100ul
Marke : Bioss
SRD5A1 (3-oxo-5-alpha-steroid 4-dehydrogenase 2) Polyclonal Antibody, APC-Cy7 Conjugated
Applications
Reactivity
Predicted Reactivity
Overview | |
Catalog # | bs-11308R-APC-Cy7 |
Product Name | SRD5A1 (3-oxo-5-alpha-steroid 4-dehydrogenase 2) Polyclonal Antibody, APC-Cy7 Conjugated |
Applications | WB |
Reactivity | Human, Bovine, Sheep, Others |
Predicted Reactivity | Mouse, Rat, Dog, Horse, Chicken |
Specifications | |
Conjugation | APC-Cy7 |
Host | Rabbit |
Source | KLH conjugated synthetic peptide derived from human SRD5A1 |
Immunogen Range | 101-200/259 |
Clonality | Polyclonal |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein A. |
Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target | |
Subcellular location | Cytoplasm, Cell membrane |
Synonyms | 3-oxo-5-alpha-steroid 4-dehydrogenase 1; SR type 1; Steroid 5-alpha-reductase 1; S5AR 1; S5A1_HUMAN. |
Background | Steroid 5a-Reductase is an important enzyme in androgen physiology because it catalyzes the conversion of testosterone into the more potent 5a-dihydro-testosterone, which mediates androgen effects on target tissues. The enzyme exists as two isoforms: type 1, which is expressed mainly in the skin; and type 2, which is expressed mainly in the prostate. In cultured human skin cells, 5a-Reductase 1 shows heterogeneity of protein, and has different levels of transcriptional and translational expression. 5a-Reductase 1 is expressed in all portions of the hair follicle, whereas 5a-Reductase 2 is expressed only in mesenchymal portions. In addition, 5a-Reductase 1 is mainly expressed in human breast carcinoma and may play a role in the in situ production and actions of the potent androgen 5a-dihydrotestosterone, including inhibition of cancer cell proliferation in hormone-dependent human breast carcinoma. The 5a-Reductase-3a-hydroxysteroid dehydrogenase complex is present in the human brain, suggesting that the complex may be involved in the synthesis of neuroactive steroids or the catabolism of neurotoxic steroids. |
Application Dilution | |
WB | 1:300-5000 |